Next Generation Sequencing Market Size, Share, and Trends 2025 to 2034

Next Generation Sequencing Market (By Product: NGS Consumables, Sequencing Services, Presequencing Products & Services, NGS Platforms, Bioinformatics, Services for NGS Platforms; By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Agriculture and Animal Research, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Others; By Technology: whole genome sequencing, Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Others; By Workflow: Pre-Sequencing, Sequencing, NGS Data Analysis; By End-use: Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Other Users) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Last Updated : 10 Nov 2025  |  Report Code : 1454  |  Category : Healthcare   |  Format : PDF / PPT / Excel

 Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Next Generation Sequencing Market 

5.1. COVID-19 Landscape: Next Generation Sequencing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Next Generation Sequencing Market, By Product

8.1. Next Generation Sequencing Market, by Product Type

8.1.1. Consumables Platforms

8.1.1.1. Market Revenue and Forecast

8.1.2. Services and Nerve Blockers

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Next Generation Sequencing Market, By Application

9.1. Next Generation Sequencing Market, by Application

9.1.1. Diagnostics

9.1.1.1. Market Revenue and Forecast

9.1.2. Biomarkers and Cancer

9.1.2.1. Market Revenue and Forecast

9.1.3. Reproductive Health

9.1.3.1. Market Revenue and Forecast

9.1.4. Personalized Medicine

9.1.4.1. Market Revenue and Forecast

9.1.5. Agriculture and Animal Research

9.1.5.1. Market Revenue and Forecast

9.1.6. Others

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global Next Generation Sequencing Market, By Technology Type 

10.1. Next Generation Sequencing Market, by Technology Type

10.1.1. Sequencing by Synthesis

10.1.1.1. Market Revenue and Forecast

10.1.2. Ion Semiconductor Sequencing

10.1.2.1. Market Revenue and Forecast

10.1.3. Sequencing by Ligation

10.1.3.1. Market Revenue and Forecast

10.1.4. Pyrosequencing

10.1.4.1. Market Revenue and Forecast

10.1.5. Single Molecule Real Time Sequencing

10.1.5.1. Market Revenue and Forecast

10.1.6. Others

10.1.6.1. Market Revenue and Forecast

Chapter 11. Global Next Generation Sequencing Market, By End User Type 

11.1. Next Generation Sequencing Market, by End User Type

11.1.1. Academic and Research Centers

11.1.1.1. Market Revenue and Forecast

11.1.2. Pharmaceutical and Biotechnology Companies

11.1.2.1. Market Revenue and Forecast

11.1.3. Hospitals and Clinics

11.1.3.1. Market Revenue and Forecast

11.1.4. Clinical Research

11.1.4.1. Market Revenue and Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Next Generation Sequencing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product

12.1.2. Market Revenue and Forecast, by Application

12.1.3. Market Revenue and Forecast, by Technology Type

12.1.4. Market Revenue and Forecast, by End User Type

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product

12.1.5.2. Market Revenue and Forecast, by Application

12.1.5.3. Market Revenue and Forecast, by Technology Type

12.1.5.4. Market Revenue and Forecast, by End User Type

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product

12.1.6.2. Market Revenue and Forecast, by Application

12.1.6.3. Market Revenue and Forecast, by Technology Type

12.1.6.4. Market Revenue and Forecast, by End User Type

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product

12.2.2. Market Revenue and Forecast, by Application

12.2.3. Market Revenue and Forecast, by Technology Type

12.2.4. Market Revenue and Forecast, by End User Type

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product

12.2.5.2. Market Revenue and Forecast, by Application

12.2.5.3. Market Revenue and Forecast, by Technology Type

12.2.5.4. Market Revenue and Forecast, by End User Type

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product

12.2.6.2. Market Revenue and Forecast, by Application

12.2.6.3. Market Revenue and Forecast, by Technology Type

12.2.6.4. Market Revenue and Forecast, by End User Type

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product

12.2.7.2. Market Revenue and Forecast, by Application

12.2.7.3. Market Revenue and Forecast, by Technology Type

12.2.7.4. Market Revenue and Forecast, by End User Type

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product

12.2.8.2. Market Revenue and Forecast, by Application

12.2.8.3. Market Revenue and Forecast, by Technology Type

12.2.8.4. Market Revenue and Forecast, by End User Type

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product

12.3.2. Market Revenue and Forecast, by Application

12.3.3. Market Revenue and Forecast, by Technology Type

12.3.4. Market Revenue and Forecast, by End User Type

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product

12.3.5.2. Market Revenue and Forecast, by Application

12.3.5.3. Market Revenue and Forecast, by Technology Type

12.3.5.4. Market Revenue and Forecast, by End User Type

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product

12.3.6.2. Market Revenue and Forecast, by Application

12.3.6.3. Market Revenue and Forecast, by Technology Type

12.3.6.4. Market Revenue and Forecast, by End User Type

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product

12.3.7.2. Market Revenue and Forecast, by Application

12.3.7.3. Market Revenue and Forecast, by Technology Type

12.3.7.4. Market Revenue and Forecast, by End User Type

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product

12.3.8.2. Market Revenue and Forecast, by Application

12.3.8.3. Market Revenue and Forecast, by Technology Type

12.3.8.4. Market Revenue and Forecast, by End User Type

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product

12.4.2. Market Revenue and Forecast, by Application

12.4.3. Market Revenue and Forecast, by Technology Type

12.4.4. Market Revenue and Forecast, by End User Type

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product

12.4.5.2. Market Revenue and Forecast, by Application

12.4.5.3. Market Revenue and Forecast, by Technology Type

12.4.5.4. Market Revenue and Forecast, by End User Type

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product

12.4.6.2. Market Revenue and Forecast, by Application

12.4.6.3. Market Revenue and Forecast, by Technology Type

12.4.6.4. Market Revenue and Forecast, by End User Type

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product

12.4.7.2. Market Revenue and Forecast, by Application

12.4.7.3. Market Revenue and Forecast, by Technology Type

12.4.7.4. Market Revenue and Forecast, by End User Type

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product

12.4.8.2. Market Revenue and Forecast, by Application

12.4.8.3. Market Revenue and Forecast, by Technology Type

12.4.8.4. Market Revenue and Forecast, by End User Type

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product

12.5.2. Market Revenue and Forecast, by Application

12.5.3. Market Revenue and Forecast, by Technology Type

12.5.4. Market Revenue and Forecast, by End User Type

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product

12.5.5.2. Market Revenue and Forecast, by Application

12.5.5.3. Market Revenue and Forecast, by Technology Type

12.5.5.4. Market Revenue and Forecast, by End User Type

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product

12.5.6.2. Market Revenue and Forecast, by Application

12.5.6.3. Market Revenue and Forecast, by Technology Type

12.5.6.4. Market Revenue and Forecast, by End User Type

Chapter 13. Company Profiles

13.1. BGI Group

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. F. Hoffmann-La Roche AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Pacific Biosciences of California Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Thermo Fisher Scientific Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Agilent Technologies Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Precigen Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Illumina Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Qiagen N.V.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. PerkinElmer Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. PierianDx Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global next-generation sequencing market size is reached at USD 15.53 billion in 2025 and is predicted to be worth around USD 60.33 billion by 2034.

The global next-generation sequencing market is expected to grow at a CAGR of 16.20% from 2025 to 2034

The major players operating in the next-generation sequencing market are BGI Group, F. Hoffmann-La Roche AG, Pacific Biosciences of California Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Precigen Inc., Illumina Inc., Qiagen N.V., PerkinElmer Inc., PierianDx Inc..

The use of next-generation sequencing in the development of customized therapeutics at the generic level is expected to increase demand for next-generation sequencing in the future years. The increased applications of next-generation sequencing (NSG) in chronic diseases and oncology are projected to drive the next-generation sequencing market.

North America region will lead the global next-generation sequencing market.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client